Dr. Gizem Calibasi-Kocal is an Associate Professor at the Department of Translational Oncology, Dokuz Eylul University, Institute of Oncology in Turkey.

She earned her PhD degrees in Basic Oncology at Dokuz Eylul University, and Medical Biochemistry at Istanbul Medipol University. During her PhD education from 2013 to 2015, she worked as a pre-doctoral research fellow at Harvard University and Stanford University, focusing on microfluidic technologies related to cancer metastasis.

From 2018 to 2020, she worked as a post-doctoral research fellow at the Massachusetts Institute of Technology (MIT), Koch Institute, focussing on adapting intestinal stem cells to different diets and their influence on intestinal cancers.

Since 2020, Dr. Calibasi-Kocal has been a faculty member in the Department of Translational Oncology at Dokuz Eylul University and leads a research group. Her main research focuses on the molecular mechanisms of colorectal cancer, with a particular emphasis on tumor microenvironment, cancer metabolism, and the dietary impacts on cancer biology.

Dr. Calibasi-Kocal’s outstanding contributions have been recognized through several awards and honors from esteemed organizations such as The Scientific and Technological Research Council of Turkey (TUBITAK), the Turkish Association for Cancer Research and Control, Organization of European Cancer Institutes (OECI), the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM).

Currently, she serves as the Associate Editor of the Journal of Basic and Clinical Health Sciences, a Dokuz Eylul University-based journal. She is also an Editorial Board Member of Artificial Intelligence in Cancer, Artificial Intelligence in Cancer, and the Journal of Biology. Dr. Calibasi-Kocal actively participates in reviewing manuscripts for various prestigious journals.